ZEEKR INTELLIGENT TECHNO-ADR (ZK)

US98923K1034 - ADR

27.55  +0.24 (+0.88%)

Premarket: 27.95 +0.4 (+1.45%)

Fundamental Rating

2

ZK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 42 industry peers in the Automobiles industry. ZK may be in some trouble as it scores bad on both profitability and health. ZK is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year ZK has reported negative net income.

1.2 Ratios

The Return On Assets of ZK (-25.74%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -25.74%
ROE N/A
ROIC N/A
ROA(3y)-36.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of ZK (15.05%) is better than 64.29% of its industry peers.
The Profit Margin and Operating Margin are not available for ZK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

ZK does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZK has a better debt/assets ratio than last year.

2.2 Solvency

ZK has an Altman-Z score of 0.37. This is a bad value and indicates that ZK is not financially healthy and even has some risk of bankruptcy.
ZK has a Altman-Z score (0.37) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACCN/A
WACC9.78%

2.3 Liquidity

A Current Ratio of 0.64 indicates that ZK may have some problems paying its short term obligations.
The Current ratio of ZK (0.64) is worse than 76.19% of its industry peers.
A Quick Ratio of 0.52 indicates that ZK may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.52, ZK is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.52

4

3. Growth

3.1 Past

The earnings per share for ZK have decreased by -5.21% in the last year.
Looking at the last year, ZK shows a very strong growth in Revenue. The Revenue has grown by 61.99%.
EPS 1Y (TTM)-5.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.43%
Revenue 1Y (TTM)61.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-81.37%

3.2 Future

Based on estimates for the next years, ZK will show a very strong growth in Earnings Per Share. The EPS will grow by 27.74% on average per year.
ZK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 41.71% yearly.
EPS Next Y55.05%
EPS Next 2Y36.16%
EPS Next 3Y27.74%
EPS Next 5YN/A
Revenue Next Year60.24%
Revenue Next 2Y50.53%
Revenue Next 3Y41.71%
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

ZK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ZK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ZK's earnings are expected to grow with 27.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.16%
EPS Next 3Y27.74%

0

5. Dividend

5.1 Amount

No dividends for ZK!.
Industry RankSector Rank
Dividend Yield N/A

ZEEKR INTELLIGENT TECHNO-ADR

NYSE:ZK (12/20/2024, 8:04:00 PM)

Premarket: 27.95 +0.4 (+1.45%)

27.55

+0.24 (+0.88%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners2.46%
Inst Owner Change-5.5%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.82B
Analysts85.33
Price Target35.52 (28.93%)
Short Float %1.1%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)48.18%
Min EPS beat(2)47.55%
Max EPS beat(2)48.81%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-9.48%
Max Revenue beat(2)8.87%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.69%
PT rev (3m)12.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)93.46%
EPS NY rev (1m)37.49%
EPS NY rev (3m)51.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.84%
Revenue NY rev (1m)-2.89%
Revenue NY rev (3m)-1.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.72
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.78
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS38.46
BVpS-5.89
TBVpS-6.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -25.74%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.05%
FCFM N/A
ROA(3y)-36.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.52
Altman-Z 0.37
F-ScoreN/A
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)511.43%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.05%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.43%
EPS Next Y55.05%
EPS Next 2Y36.16%
EPS Next 3Y27.74%
EPS Next 5YN/A
Revenue 1Y (TTM)61.99%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-81.37%
Revenue Next Year60.24%
Revenue Next 2Y50.53%
Revenue Next 3Y41.71%
Revenue Next 5YN/A
EBIT growth 1Y-14.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year28.64%
EBIT Next 3Y30.02%
EBIT Next 5YN/A
FCF growth 1Y108.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y164.57%
OCF growth 3YN/A
OCF growth 5YN/A